01 September 2022 : Clinical Research
High Level of Irisin as a Marker of Malnutrition in Head and Neck Cancer Patients Subjected to Radiotherapy
Iwona Homa-Mlak1ACDEF*, Radosław Mlak1ACDEF, Anna Brzozowska2BDF, Marcin Mazurek1CEF, Tomasz Powrózek1CDE, Monika Prendecka-Wróbel1CEF, Aneta Szudy-Szczyrek2ADE, Piotr Dreher3CEF, Katarzyna Kamińska4F, Teresa Małecka-Massalska1ACEF, Alicja Wójcik-Załuska5CEGDOI: 10.12659/MSM.936857
Med Sci Monit 2022; 28:e936857
Table 1 Characteristic of the study group.
| Factor | Study group (n=50) | |
|---|---|---|
| Gender | Male | 44 (88%) |
| Female | 6 (12%) | |
| Age (years) | ≥65 | 21 (42%) |
| <65 | 29 (58%) | |
| Histopathological diagnosis | Carcinoma planoepitheliale | 46 (92%) |
| Other | 4 (8%) | |
| Tumor location | Upper and middle | 11 (22%) |
| Lower | 39 (78%) | |
| Lower and middle | 45 (90%) | |
| Upper | 5 (10%) | |
| T stage | T1–T2 | 10 (20%) |
| T3–T4 | 40 (80%) | |
| N stage | N0 | 16 (32%) |
| N1–N3 | 34 (68%) | |
| M stage | Mx | 2 (4%) |
| M0 | 47 (94%) | |
| M1 | 1 (2%) | |
| Performance status (ECOG) | 1 | 46 (92%) |
| 2 | 4 (8%) | |
| Alcohol consumption | Yes | 21 (42%) |
| No | 29 (58%) | |
| Tobacco smoking | Yes | 42 (84%) |
| No | 8 (16%) | |
| ECOG – Eastern Cooperative Oncology Group; M – metastatic spread; N – lymph node involvement; T – tumor site and size; TNM – Tumor, Node, Metastasis staging. | ||